Cystic fibrosis-related liver disease: Clinical presentations, diagnostic and monitoring approaches in the era of CFTR modulator therapies-Reference-Cited by-同舟云学术

Cystic fibrosis-related liver disease: Clinical presentations, diagnostic and monitoring approaches in the era of CFTR modulator therapies

Published:2022-02 Issue:2 Volume:76 Page:420-434
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Dana Jérémy,Debray Dominique^ORCID,Beaufrère Aurélie,Hillaire Sophie,Fabre Monique^ORCID,Reinhold Caroline,Baumert Thomas F.,Berteloot Laureline,Vilgrain Valérie

Publisher

Elsevier BV

Subject

Hepatology

Reference155 articles.

1. Cystic fibrosis liver disease: outcomes and risk factors in a large cohort of French patients;Boëlle;Hepatology,2019

2. Epidemiology of liver disease in cystic fibrosis: a longitudinal study;Lamireau;J Hepatol,2004

3. Liver transplantation in adult cystic fibrosis: clinical, imaging, and pathological evidence of obliterative portal venopathy;Hillaire;Liver Transplant,2017

4. Cystic fibrosis-related liver disease: research challenges and future perspectives;Debray;J Pediatr Gastroenterol Nutr,2017

5. Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome;Colombo;Hepatology,2002

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prominent role of gut dysbiosis in the pathogenesis of cystic fibrosis-related liver disease in mice;Journal of Hepatology;2024-09

2. Early detection of hepatobiliary involvement in cystic fibrosis: Biomarkers, radiologic methods, and genetic influences;Pediatric Pulmonology;2024-08-06

3. Cystic fibrosis hepatobiliary involvement: an update on imaging in diagnosis and monitoring;Pediatric Radiology;2024-07-22

4. Modified by the Innovative Drugs and Strategies—Pattern of Selected Indications for Pediatric Liver Transplantation;Pediatric Transplantation;2024-07-13

5. Case Series: Hyperbilirubinemia under elexacaftor/tezacaftor/ivacaftor in the presence of Gilbert’s syndrome;BMC Pulmonary Medicine;2024-07-01